Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11942106
[patent_doc_number] => 20170246256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'METHODS OF ADMINISTERING HEPCIDIN'
[patent_app_type] => utility
[patent_app_number] => 15/399936
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13065
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15399936
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/399936 | METHODS OF ADMINISTERING HEPCIDIN | Jan 5, 2017 | Abandoned |
Array
(
[id] => 11589703
[patent_doc_number] => 20170114114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION'
[patent_app_type] => utility
[patent_app_number] => 15/398627
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 41847
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398627
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398627 | ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION | Jan 3, 2017 | Abandoned |
Array
(
[id] => 11820596
[patent_doc_number] => 20170209533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'ANTIMICROBIAL COMPOSITIONS AND METHOD OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/397359
[patent_app_country] => US
[patent_app_date] => 2017-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11007
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15397359
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/397359 | Antimicrobial compositions and method of use thereof | Jan 2, 2017 | Issued |
Array
(
[id] => 11602547
[patent_doc_number] => 20170119847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'SHORT BETA-DEFENSIN-DERIVED PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/391979
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18609
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15391979
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/391979 | SHORT BETA-DEFENSIN-DERIVED PEPTIDES | Dec 27, 2016 | Abandoned |
Array
(
[id] => 11568605
[patent_doc_number] => 20170107250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'ANTIMICROBIAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/391167
[patent_app_country] => US
[patent_app_date] => 2016-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12422
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15391167
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/391167 | ANTIMICROBIAL COMPOUNDS | Dec 26, 2016 | Abandoned |
Array
(
[id] => 11588444
[patent_doc_number] => 20170112854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'Misoprostol Composition'
[patent_app_type] => utility
[patent_app_number] => 15/388157
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8587
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15388157
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/388157 | Misoprostol Composition | Dec 21, 2016 | Abandoned |
Array
(
[id] => 13778211
[patent_doc_number] => 20190002644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => Method for Producing Polymer Aggregate
[patent_app_type] => utility
[patent_app_number] => 16/065391
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/065391 | Method for Producing Polymer Aggregate | Dec 20, 2016 | Abandoned |
Array
(
[id] => 13729749
[patent_doc_number] => 20180369342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => CARDIAC METABOLIC EFFECT OF LANTUS
[patent_app_type] => utility
[patent_app_number] => 16/064313
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064313
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/064313 | CARDIAC METABOLIC EFFECT OF LANTUS | Dec 20, 2016 | Abandoned |
Array
(
[id] => 11542647
[patent_doc_number] => 20170096473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'HUMAN PLACENTAL COLLAGEN COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/384170
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 33095
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15384170
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/384170 | HUMAN PLACENTAL COLLAGEN COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | Dec 18, 2016 | Abandoned |
Array
(
[id] => 14338897
[patent_doc_number] => 20190151421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => METHOD FOR PREVENTING OR TREATING LIVER TISSUE DAMAGE AND ASSOCIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/062389
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062389
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062389 | METHOD FOR PREVENTING OR TREATING LIVER TISSUE DAMAGE AND ASSOCIATED DISEASES | Dec 15, 2016 | Abandoned |
Array
(
[id] => 12143813
[patent_doc_number] => 09878050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-30
[patent_title] => 'Delivery of agents using interfering nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 15/374679
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 49256
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15374679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/374679 | Delivery of agents using interfering nanoparticles | Dec 8, 2016 | Issued |
Array
(
[id] => 11729257
[patent_doc_number] => 20170190700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'Emetine Derivatives, Prodrugs Containing Same, And Methods Of Treating Conditions Using Same'
[patent_app_type] => utility
[patent_app_number] => 15/352290
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8000
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15352290
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/352290 | Emetine Derivatives, Prodrugs Containing Same, And Methods Of Treating Conditions Using Same | Nov 14, 2016 | Abandoned |
Array
(
[id] => 11962101
[patent_doc_number] => 20170266254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'PEPTIDOMIMETIC MACROCYCLES'
[patent_app_type] => utility
[patent_app_number] => 15/349478
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25904
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349478
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349478 | Peptidomimetic macrocycles | Nov 10, 2016 | Issued |
Array
(
[id] => 11588529
[patent_doc_number] => 20170112940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'Modified Collagen Hybridizing Peptides And Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/331348
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14788
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15331348
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/331348 | Modified Collagen Hybridizing Peptides And Uses Thereof | Oct 20, 2016 | Abandoned |
Array
(
[id] => 11528608
[patent_doc_number] => 20170088585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'CYCLIC PEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/289205
[patent_app_country] => US
[patent_app_date] => 2016-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8836
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15289205
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/289205 | CYCLIC PEPTIDES AND USES THEREOF | Oct 9, 2016 | Abandoned |
Array
(
[id] => 16590777
[patent_doc_number] => 10900027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Recombinant prothrombin analogues and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/766901
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14158
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766901 | Recombinant prothrombin analogues and uses thereof | Oct 6, 2016 | Issued |
Array
(
[id] => 13397635
[patent_doc_number] => 20180250360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => METHOD FOR DETECTING CANCER CELLS, REAGENT FOR INTRODUCING SUBSTANCE INTO CANCER CELLS, AND COMPOSITION FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 15/759288
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759288
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/759288 | METHOD FOR DETECTING CANCER CELLS, REAGENT FOR INTRODUCING SUBSTANCE INTO CANCER CELLS, AND COMPOSITION FOR TREATING CANCER | Oct 4, 2016 | Abandoned |
Array
(
[id] => 11497823
[patent_doc_number] => 20170072009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'POLYPEPTIDE INHIBITORS OF HSP27 KINASE AND USES THERFOR'
[patent_app_type] => utility
[patent_app_number] => 15/280722
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20458
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15280722
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/280722 | Polypeptide inhibitors of HSP27 kinase and uses therfor | Sep 28, 2016 | Issued |
Array
(
[id] => 11866148
[patent_doc_number] => 20170233434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'METHOD FOR SEPARATING PROTEINS FROM ANIMAL OR HUMAN PLASMA, OR PLANTS, USING A PH GRADIENT METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/278699
[patent_app_country] => US
[patent_app_date] => 2016-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2047
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15278699
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/278699 | Method for separating proteins from animal or human plasma, or plants, using a pH gradient method | Sep 27, 2016 | Issued |
Array
(
[id] => 13425267
[patent_doc_number] => 20180264176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => INJECTABLE MACROPOROUS HYDROGELS
[patent_app_type] => utility
[patent_app_number] => 15/758390
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758390
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/758390 | INJECTABLE MACROPOROUS HYDROGELS | Sep 7, 2016 | Abandoned |